Chlamydia Follow-up
- Author: Mounir Bashour, MD, CM, FRCS(C), PhD, FACS; Chief Editor: Hampton Roy Sr, MD more...
Further Outpatient Care
- Patients should be observed 2-6 weeks after initiation of treatment, depending on the severity of the initial symptoms.
Deterrence/Prevention
- Patients should follow safe sexual practices, including the use of condoms.
Prognosis
- Prognosis is excellent with treatment.
Patient Education
- Educate patients about the risks of sexually transmitted diseases and safe sexual practices.
- For excellent patient education resources, visit eMedicine's Sexually Transmitted Diseases Center. Also, see eMedicine's patient education articles Sexually Transmitted Diseases and Chlamydia.
Rackstraw S, Viswalingam ND, Goh BT. Can chlamydial conjunctivitis result from direct ejaculation into the eye?. Int J STD AIDS. Sep 2006;17(9):639-41. [Medline].
Coppens I, Abu el-Asrar AM, Maudgal PC, Missotten L. Incidence and clinical presentation of chlamydial keratoconjunctivitis: a preliminary study. Int Ophthalmol. 1988;12(4):201-5. [Medline].
Salopek-Rabatic J. Chlamydial conjunctivitis in contact lens wearers: successful treatment with single dose azithromycin. CLAO J. Oct 2001;27(4):209-11. [Medline].
Bersudsky V, Rehany U, Tendler Y, Leffler E, Selah S, Rumelt S. Diagnosis of chlamydial infection by direct enzyme-linked immunoassay and polymerase chain reaction in patients with acute follicular conjunctivitis. Graefes Arch Clin Exp Ophthalmol. Aug 1999;237(8):617-20. [Medline].
Blake IM, Burton MJ, Bailey RL, Solomon AW, West S, Muñoz B, et al. Estimating Household and Community Transmission of Ocular Chlamydia trachomatis. PLoS Negl Trop Dis. 2009;3(3):e401. [Medline].
[Guideline] American Academy of Ophthalmology Cornea/External Disease Panel. Conjunctivitis. National Guideline Clearinghouse. 2008.
[Guideline] U.S. Preventive Services Task Force. Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Oct 7 2008;149(7):491-6, W95. [Medline].
Carta F, Zanetti S, Pinna A, Sotgiu M, Fadda G. The treatment and follow up of adult chlamydial ophthalmia. Br J Ophthalmol. Mar 1994;78(3):206-8. [Medline].
Elnifro EM, Storey CC, Morris DJ, Tullo AB. Polymerase chain reaction for detection of Chlamydia trachomatis in conjunctival swabs. Br J Ophthalmol. Jun 1997;81(6):497-500. [Medline].
Haller-Schober EM, El-Shabrawi Y. Chlamydial conjunctivitis (in adults), uveitis, and reactive arthritis, including SARA. Sexually acquired reactive arthritis. Best Pract Res Clin Obstet Gynaecol. Dec 2002;16(6):815-28. [Medline].
Kalayoglu MV. Ocular chlamydial infections: pathogenesis and emerging treatment strategies. Curr Drug Targets Infect Disord. Mar 2002;2(1):85-91. [Medline].
Miller K, Schmidt G, Melese M. How reliable is the clinical exam in detecting ocular chlamydial infection?. Ophthalmic Epidemiol. Jul 2004;11(3):255-62. [Medline].
Nakagawa H. Treatment of chlamydial conjunctivitis. Ophthalmologica. 1997;211 Suppl 1:25-8. [Medline].
Numazaki K, Chiba S, Aoki K. Evaluation of serological tests for screening of chlamydial eye diseases. In Vivo. May-Jun 1999;13(3):235-7. [Medline].
Stenberg K, Mardh PA. Genital infection with Chlamydia trachomatis in patients with chlamydial conjunctivitis: unexplained results. Sex Transm Dis. Jan-Mar 1991;18(1):1-4. [Medline].
Taylor HR, Fitch CP, Murillo-Lopez F, Rapoza P. The diagnosis and treatment of chlamydial conjunctivitis. Int Ophthalmol. 1988;12(2):95-9. [Medline].

